Cohort study

Vigorous Exercise in Patients With Hypertrophic Cardiomyopathy

JAMA CardiolPublished

  • Prospective cohort study
  • investigator-initiated
  • multicenter
  • observational registry
  • 42 hypertrophic cardiomyopathy (HCM) centers in the US and internationally

Authors' conclusion

Results of this cohort study suggest that among individuals with HCM or those who are genotype positive/phenotype negative and are treated in experienced centers, those exercising vigorously did not experience a higher rate of death or life-threatening arrhythmias than those exercising moderately or those who were sedentary.

Study context

Population
Individuals aged 8 to 60 years with HCM or genotype positive/phenotype negative, without conditions precluding exercise
Participants
1,660 individuals
Exposure
Vigorous exercise vs nonvigorous activity
  • Vigorousn = 699
Outcome
Composite of:
  • Death
  • Resuscitated sudden cardiac arrest
  • Arrhythmic syncope
  • Appropriate ICD shock

Main finding

As reported in the abstract

Adjusted hazard ratio

1.01

95% 1-sided CI upper 1.48

Events by group

Observational data: associations, not effects.

Original publication

Vigorous Exercise in Patients With Hypertrophic Cardiomyopathy. JAMA Cardiol. Published 1 June 2023. doi:10.1001/jamacardio.2023.1042

Summarised from the published abstract; every number is checked against it